Arkolith/Insider Trading/MIRO/Form 4

Ross Jeffrey James

CHIEF EXECUTIVE OFFICER, DirectorMiromatrix Medical Inc. (MIRO) · full profile →Form 4 · filed Dec 13, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
11
2 non-derivative · 9 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 13, 2023Disposed to issuer(D)88K——0
Dec 12, 2023Tender(U)309K——88K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 13, 2023Disposed to issuer(D)100K——0
Dec 13, 2023Disposed to issuer(D)100K——0
Dec 13, 2023Disposed to issuer(D)69K——0
Dec 13, 2023Disposed to issuer(D)100K——0
Dec 13, 2023Disposed to issuer(D)39K——0
Dec 13, 2023Disposed to issuer(D)34K——0
Dec 13, 2023Disposed to issuer(D)44K——0
Dec 13, 2023Disposed to issuer(D)41K——0
Dec 13, 2023Disposed to issuer(D)2K——0

Transaction Codes

D
Disposition to the issuer
U
See SEC Form 4 code table

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-23-016371) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML